Abbott India Ltd. benchmarking: Perfomance to industry peers

Financial

	Abbott India	Alkem Laboratories	Glenmark Pharma
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	8.2 %	73.0 %	10.3 %
R&D as a % of Total Sales	0.02 %	3.3 %	7.3 %
Financials
5 yr Average ROE	30.11 %	17.38 %	3.99 %
5yr average Equity Multiplier	1.43	1.39	1.78
5yr Average Asset Turnover Ratio	1.14	0.86	0.8
5yr Avg Net Profit Margin	18.53 %	14.54 %	2.85 %
Price to Book	15.31	5.06	5.79
P/E	40.69	28.62	54.94
5yr Avg Cash Conversion Cycle	-46.68 Days	-61.46 Days	-150.94 Days
Inventory Days	45.22 Days	56.11 Days	32.28 Days
Days Receivable	19.34 Days	44.62 Days	32.34 Days
Days Payable	109.21 Days	122.42 Days	201.14 Days
5yr Average Interest Coverage Ratio	97.37	24.48	4.25
5yr Avg ROCE	38.77 %	22.76 %	17.54 %
5yr Avg Operating Profit Margin	23.42 %	18.44 %	15.96 %
5 yr average Debt to Equity	0.0	0.18	0.38
5yr CAGR Net Profit	15.41 %	6.44 %	1.54 %
5yr Average Return on Assets	21.03 %	12.47 %	2.09 %
Shareholdings
Promoter Holding	74.99 %	51.2 %	46.65 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-5.96 %	0.0
Change in Mutual Fund Holding (3 Yrs)	2.11 %	7.52 %	10.05 %

Business

	Abbott India	Alkem Laboratories	Glenmark Pharma
Product Wise Break-Up	Product Wise Break-Up Anti Diabetic 42.82 Gastro Intestinal 25.46 Central Nervous System (CNS) 12.65 Hormones 11.59 Women`s health 7.48 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Pain 0 Pharmaceutical 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0	Product Wise Break-Up Respiratory 0 Gastro Intestinal 0 Glenmark Pharma (Branded generics) 0 Pharmaceutical 100.0 Hormones 0 Pain 0 Anti Diabetic 0 Vitamin, Minerals & Nutrition 0 Vaccines 0 cardiovascular system 0 Metabolic 0 Hepatoprotectives 0 Women`s health 0 Anti-Infectives 0 Glenmark generics 0 Derma 0 Central Nervous System (CNS) 0	Product Wise Break-Up Respiratory 0 Gastro Intestinal 0 Branded Generics 60.46 Pharmaceutical 0 Hormones 0 Pain 0 Anti Diabetic 0 Vitamin, Minerals & Nutrition 0 Vaccines 0 cardiovascular system 0 Metabolic 0 Hepatoprotectives 0 Women`s health 0 Anti-Infectives 0 Formulations 39.54 Derma 0 Central Nervous System (CNS) 0
Location Wise Break-Up	Location Wise Break-Up India 98.81 Rest of the World 1.19 USA 0 Europe 0 Latin America 0 North America 0	Location Wise Break-Up India 69.13 Latin America 0 USA 29.72 Europe 0 North America 0 Rest of the World 0 Others 1.15	Location Wise Break-Up India 2.73 Latin America 0 USA 0 Europe 12.36 North America 73.99 Rest of the World 10.91 Others 0.01
Acute vs Chronic	Acute vs Chronic Chronic 46.0 Acute 27.0 Sub-chronic 27.0	-	-
Dosage Form Break-Up	Dosage Form Break-Up Injectable 39.89 Tablet 39.17 Liquids 15.9 Capsule 3.47 Ointment 0.27 Granules 0.23 Powder 0.19 Others 0.88	-	-
Brand Wise Break-Up	Brand Wise Break-Up Mixtard 19.93 Thyronorm 14.04 Ryzodeg 11.83 Udiliv 11.03 Novomix 9.31 Duphaston 8.88 Duphalac 6.69 Vertin 6.67 Novo Rapid 5.92 Cremaffin Plus 5.69 Claribid 0 Cremaffin 0 Similac 0 Ensure 0 Others 0.01	-	-

Abbott India Ltd.

Abbott India Ltd.

Financial

Business

SIGN UP FOR FREE